Connecting ideas

Bridging data to compile unique products 

Research and Development

> Development of analytical methods
> Reverse engineering/ Investigation of the 

   reference product composition
"Essential similarity” establishment for generics
> Dissolution development
> ​​​​​​​Skin Permeation Studies 
> Extraction studies for primary packaging

   and manufacturing materials
> Elemental impurities (ICH Q3D guideline)

> Development of analytical methods
> Reverse engineering/ Investigation of the 

   reference product composition
> Essential similarity” establishment for 

   generics
> Dissolution development
> Permeation studies 
> Extraction studies for primary packaging

   and manufacturing materials
> Elemental impurities (ICH Q3D guideline)

Validation activities

> Validation of analytical methods
> Forced degradation studies 
> Leachables testing
> Cleaning validation / PDE establishment
> Stability studies  
> Filter validation 

Quality Control / Post approval services

> Batch Testing/ Release of API’s,

   Excipients, Packaging and Final Products
> QP services
> Post approval (ongoing) stability studies
> Post Approval Management/ Lifecycle

   strategy

Medical Devices

> Regulatory Affairs
> Cytotoxicity testing
> Sensitization Testing
> Irritation Testing

Scroll down

QualiMetriX is a lifetime project that was born through years of experience and teamwork and aims to utilize the human resources, equipment and expertise for the benefit of pharmaceutical industry.
QualiMetriX staff comprise highly motivated research experts – graduated specialists with PhD and MSc, experienced in pharmacy, chemistry and related sciences.
Within the years of company’s operation, we have been involved in the approval of hundreds of pharmaceutical products worldwide and a significant number of studies have been performed on behalf of European and Global pharmaceutical companies.


Our ambitions for the future mainly apply at three levels:

The technology: 

Implementation of state-of-the-art instrumentation and robotic integrated systems in order to build up fully automated procedures which will reduce the manual handling to minimum. In parallel fully integrated and validated computerized systems will be adopted in order to attain an electronical, ultimately paperless, quality management system.

The science: 

To expand our field of expertise to biotech products and advanced therapies. 

The impact to the pharmaceutical industry: 

To complete the construction of the high-tech training center and provide training to young as well as senior scientists in the field. The company will act as a cutting edge and open source point, where information and know-how will be available to everyone. The community of QualiMetrix to be widen and include fresh scientific brains, which by working in a high-level scientific environment should have the opportunity to prove their potential and develop their capabilities, both for the benefit of the CRO as well as for the benefit of the end user; the pharmaceutical industry.

Go to article: Home | Mapping the MindGo to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: EditorialGo to article: Biocorp Company InsightGo to article: BiocorpGo to article: ContentsGo to article: Fisher Clinical ServicesGo to article: Malvern Panalytical Company InsightGo to article: Malvern PanalyticalGo to article: NewsGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The Pharma Industry BriefingGo to article: Mattler ToledoGo to article: MedelpharmGo to article: HPV vaccines: a decade of progressGo to article: Nipro PharmaPackagingGo to article: PfanstiehlGo to article: Hereditary Alzheimer’s: could rare genes hold the clue to a cure?Go to article: SGSGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: Could a unique brain fingerprint predict a drug’s effectiveness?Go to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Genetic studies: a powerful tool for testing combination therapiesGo to article: Nelson Lab Company InsightGo to article: Nelson LabGo to article: Abiogen PharmaGo to article: The Express Scripts story; super-pharmacies and the US drug industryGo to article: B Medical SystemsGo to article: Daiichi JitsugyoGo to article: LaudaGo to article: Is a lack of female participants skewing heart disease trial results?Go to article: EcocoolGo to article: HOF SonderanlagenbauGo to article: DiverseyGo to article: Why the German Centre for Diabetes Research changed its approach to handling dataGo to article: Dow Europe GmbH Company InsightGo to article: Dow Europe GmbHGo to article: QualiMetriXGo to article: How digital innovation is helping to drive transformation in regulatory affairs Go to article: DryceGo to article: ILC Dover IncGo to article: Pall BiotechGo to article: EventsGo to article: Event: Pharmpack EuropeGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: Unither PharmaceuticalsGo to article: Next issueGo to article: ButterworthGo to article: myLiquitab